Christopher J Welsh
Biographic Data
| ID | 10406109 |
|---|---|
| NAME | Christopher J Welsh |
| GIVEN NAMES | Christopher J |
| FAMILY NAME | Welsh |
| SIGNATURE | WELSH C J |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Telemedicine-based buprenorphine initiation and maintenance in rural jails
The persistent U.S. opioid overdose epidemic disproportionately affects incarcerated populations, who face a severely heightened risk of fatal overdose after release. Providing medications for opioid use disorder (MOUD) in jails significantly reduces post-release death and boosts community treatment engagement, making short-term carceral stays a vital window for intervention. But access to MOUD, especially in rural areas, is greatly hampered by l…
Buprenorphine Induction in a Rural Maryland Detention Center During Covid-19
Over 10 million individuals pass through U.S. detention centers on an annual basis, with nearly two-thirds meeting criteria for drug dependence/abuse. Despite proven efficacy, treatment with medications for opioid use disorder (MOUD) is underutilized in jail settings-a gap that could be addressed using telemedicine. Here we describe a new program of telemedicine-based clinical provision of new/continuing buprenorphine treatment for individuals de…
No prominent works on this page.
Buprenorphine Induction in a Rural Maryland Detention Center During Covid-19
Over 10 million individuals pass through U.S. detention centers on an annual basis, with nearly two-thirds meeting criteria for drug dependence/abuse. Despite proven efficacy, treatment with medications for opioid use disorder (MOUD) is underutilized in jail settings-a gap that could be addressed using telemedicine. Here we describe a new program of telemedicine-based clinical provision of new/continuing buprenorphine treatment for individuals de…
Telemedicine-based buprenorphine initiation and maintenance in rural jails
The persistent U.S. opioid overdose epidemic disproportionately affects incarcerated populations, who face a severely heightened risk of fatal overdose after release. Providing medications for opioid use disorder (MOUD) in jails significantly reduces post-release death and boosts community treatment engagement, making short-term carceral stays a vital window for intervention. But access to MOUD, especially in rural areas, is greatly hampered by l…
Buprenorphine (2 works) · Opioid use disorder (2 works) · Opioid Use Disorder Treatment (2 works) · Substance Abuse Treatment and Outcomes (2 works) · Telemedicine (2 works) · access to addiction treatment (1 work) · Coronavirus disease 2019 (COVID-19 (1 work) · COVID-19 and Mental Health (1 work) · drug diversion (1 work) · Health care (1 work)